These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7251793)

  • 1. Determination of three main antileprosy drugs and their main metabolites in serum by high-performance liquid chromatography.
    Gidoh M; Tsutsumi S; Takitani S
    J Chromatogr; 1981 May; 223(2):379-92. PubMed ID: 7251793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and interactions of antileprosy drugs.
    George J
    Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations.
    Borner K; Hartwig H; Leitzke S; Hahn H; Müller RH; Ehlers S
    Int J Antimicrob Agents; 1999 Jan; 11(1):75-9. PubMed ID: 10075282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined dapsone and clofazimine intoxication.
    Hoetelmans RM; Otten JM; Koks CH; Soesan M; Beijnen JH
    Hum Exp Toxicol; 1996 Aug; 15(8):625-8. PubMed ID: 8863056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of serum and tissue levels of phenazines including clofazimine.
    O'Connor R; O'Sullivan JF; O'Kennedy R
    J Chromatogr B Biomed Appl; 1996 Jun; 681(2):307-15. PubMed ID: 8811441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic method with ultraviolet detection for the determination of dapsone and its hydroxylated metabolite in human plasma.
    Kwadijk S; Toraño JS
    Biomed Chromatogr; 2002 May; 16(3):203-8. PubMed ID: 11920946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic determination of rifapentine in serum using column switching.
    Lee HS; Shin HC; Han SS; Roh JK
    J Chromatogr; 1992 Feb; 574(1):175-8. PubMed ID: 1629284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on drug interactions.
    Venkatesan K; Bharadwaj VP; Ramu G; Desikan KV
    Lepr India; 1980 Apr; 52(2):229-35. PubMed ID: 7453137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenic activity of antileprosy drugs and their derivatives.
    Peters JH; Gordon GR; Murray JF; Simmon VF
    Int J Lepr Other Mycobact Dis; 1983 Mar; 51(1):45-53. PubMed ID: 6683259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed clearance of circulating immune complexes in mice following administration of antileprosy drugs.
    Kashyap A; Saha K; Sahu A; Chakrabarty AK; Chattopadhya D
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):404-9. PubMed ID: 1474278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone distribution study of anti leprotic drug clofazimine in rat bone marrow cells by a sensitive reverse phase liquid chromatography method.
    Srikanth CH; Joshi P; Bikkasani AK; Porwal K; Gayen JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():82-6. PubMed ID: 24792531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acute dapsone poisoning: toxicological data and review of the literature.
    Tracqui A; Gutbub AM; Kintz P; Mangin P
    J Anal Toxicol; 1995; 19(4):229-35. PubMed ID: 8531468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of clofazimine on the pharmacokinetics of rifampicin and dapsone in leprosy.
    Venkatesan K; Mathur A; Girdhar BK; Bharadwaj VP
    J Antimicrob Chemother; 1986 Dec; 18(6):715-8. PubMed ID: 3818497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of several antileprosy drugs on immunological state of experimental animals.
    Gidoh M; Tsutsumi S; Narita M; Fukushi K
    Nihon Rai Gakkai Zasshi; 1980; 48(4):159-70. PubMed ID: 7380761
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromatographic method for the simultaneous quantification of dapsone and clofazimine in nanoformulations.
    Machado S; Fernandes SR; Chaves LL; Lima SAC; Silva EMP; Barreiros L; Reis S; Segundo MA
    J Sep Sci; 2018 Sep; 41(17):3382-3388. PubMed ID: 30006947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorometric method for the simultaneous determination of 4,4'-diaminodiphenyl sulfone (DDS), N-acetyl-DDS (MADDS) and N,N'-diacetyl-DDS (DADDS) in serum or urine.
    Ellard GA; Gammon PT
    Int J Lepr Other Mycobact Dis; 1969; 37(4):398-405. PubMed ID: 5394260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Simultaneous determination of vinburnine and 6-hydroxyvinburnine in human plasma by high-performance liquid chromatography].
    Sado PA; Gibassier D; Leverge R
    J Chromatogr; 1988 Dec; 434(1):157-67. PubMed ID: 3243809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of drug regimen in lepromatous leprosy--II.
    Ramu G; Sreevatsa
    Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.